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Synthesis and structural characterization of N(4)-substituted 2-acetylpyridine-N(4)-methyl-3-thiosemicarbazone (L) and 
its two metal complexes [Cu(L)(OAc)] (1) and [ZnL(OAc)]2 (2) are reported. Between the two complexes 1 is found to have 
good anticancer activity against Human lung cancer cell line (A549). Fluorescence microscopy finds the formation of 
reactive oxygen species on treatment of the cancer cells with 1. The IC50 value of the complex is measured as 0.72 M 
which is lower than that of cisplatin against A549. 
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Thiosemicarbazones are an important class of (N, S) 
donor ligands having its thione and thiolate tautomeric 
forms, and showing a number of biological activities1,2. 
Several coordination modes of these ligands towards 
metal centres have made them interesting3 in designing 
metal based cancer chemotherapeutic drugs. Cisplatin 
and related platinum drugs fascinated the coordination 
chemists during last few decades4 as an alternative to 
cancer treatments. But the limitation of these 
compounds towards successful cancer chemotherapy is 
due to their DNA mismatch repair. For this very reason 
different first row transition metal-based drugs are now 
being synthesized3-5 as an alternative to cisplatin and its 
derivatives. The additional advantage in this type of 
drugs is that the most of the transition metals used are 
essential trace elements in human physiological 
systems. In case of thiosemicarbazones, the ligand 
backbone often plays an important role in exhibiting 
biological activities. Moreover, the biological activities 
of metal thiosemicarbazones are highly dependent on 
various substitutions on the ligand framework. 
According to previous reports6,7, substitution on 
terminal nitrogen [N(4)] of the thiosemicarbazones 
makes significant changes in their activities. In 
continuation to our earlier interests in designing 
transition metal based cancer chemotherapeutic 
agents8, here we have designed and synthesized a N(4)-
substituted 2-acetylpyridine-N(4)-methyl-3-thiose-
micarbazone (L) (Scheme 1) and their two transition 
metal complexes CuL(OAc) (1) and [ZnL(OAc)]2 (2). 
The ligand and each of the metal complexes are 
characterized X-ray crystallographically. Crystal 
structure of L was previously reported9. The complexes 
along with the ligand here reported are used in 
investigating the anticancer activity against human lung 
cancer cell line. Except the complex 1, other 
compounds were found similarly toxic to normal 
healthy cells. So, the detailed investigation regarding 
cell viability, reactive oxygen species (ROS) generation, 
etc. are performed using the complex 1 only.  
Materials and Methods 
Materials 
2-acetylpyridine (Sigma-Aldrich, UK), 4-methyl-3-
thiosemicarbazide (Sigma-Aldrich, UK), zinc(II) acetate 
dihydrate (SRL, India), copper(II) acetate dihydrate 
(SRL, India) were purchased and used as received. 
Solvents were dried using standard procedure and 
distilled before use. 
Physical measurements 
Elemental analyses (carbon, hydrogen and nitrogen) 
were performed on a PerkinElmer 2400 CHNS/O 
Scheme 1 — Molecular structure of 2-acetylpyridine-N(4)-
methyl-3-thiosemicarbazone (L) 




elemental analyzer. UV-visible absorption, IR (KBr 
discs, 4000-500 cm-1) and 1H-NMR spectra were 
recorded using a Shimadzu UV-Vis 2450 
spectrophotometer, PerkinElmer FT-IR model RX1 
spectrometer and Bruker Advance III 500 MHz (and 
400 MHz) NMR spectrometer, respectively. 
 
X-ray diffraction 
Single crystals of L, 1 and 2 suitable for X-ray 
crystallographic analysis were selected following 
examination under a microscope. Diffraction data at  
293 K (for L) and 296 K (for 1 and 2) were collected on 
Bruker-Kappa APEX  CCD diffractometer using  
Cu-Kα (λ = 1.54184 Å) and Mo-Kα radiations  
(λ = 0.71073 Å), respectively. The data collection 
parameters and crystal data are listed in Table 1. The 
compounds L and 1 were crystallized in P21/c, and 2 
were in P21/n, respectively. Of 8159 (L), 26816 (1) and 
23481(2) collected reflections, respective 2050, 3404 
and 2966 unique reflections with I2σ(I) were used for 
structure solution. The structures were solved by direct 
methods and the structure solution and refinement were 
based on |F|2. The final differences Fourier map showed 
the maximum and minimum peak heights at 0.405 and  
-0.303 eÅ-3 for L, 0.616 and -0.404 eÅ-3 for 1, 0.704 and  
-0.514 eÅ-3 for 2 with no chemical significance. All 
calculations were carried out using SHELXL-9710 and 
ORTEP-3211. 
 
Synthesis of ligand and its metal complexes 
 
Synthesis of N(4)-substituted 2-acetylpyridine-N(4)-methyl-3-
thiosemicarbazone L 
The ligand L was synthesized by a modified 
reported method9. Ethanolic solution (50 mL) of  
2-acetylpyridine (230.77 mg, 1.905 mmol) and  
4-methyl-3-thiosemicarbazide (200.00 mg, 1.905 mmol) 
were mixed in a 100 mL round bottom flask. The 
reaction mixture was refluxed for 10 h. On evaporation 
of the final ethanolic mixture on steam bath off white 
block shaped crystals appeared. It was dried in vacuo 
and dissolved in ethanol for recrystallization. Single 
crystals of L were appeared after a week.  
 
Yield: 0.278 g (70%), Anal. for C9H12N4S (L):  
Calcd. (%) C, 51.89; H, 05.80; N, 26.89; found (%), 
C, 51.77; H, 05.75; N, 26.99; Selected IR bands (KBr 
pellet, cm-1):1606.00 (C=N), 778.99 (C-S); UV-visible 
absorption (λ, nm): 320; 1H NMR (CDCl3, 500 MHz): 
δH (ppm) = 2.35 (s, 3H), 3.22 (d, 3H. J = 6Hz), 7.63 
(m, 1H), 7.64-8.68 (m, 4H). 
 
Synthesis of CuL(OAc) (1) 
Copper(II) acetate dihydrate (19.96 mg, 0.1 mmol) 
was slowly added to the ethanolic solution of L 
(20.81 mg, 0.1 mmol) and the reaction mixture was 
stirred for about 3 h. The resulting solution turned 
light yellow and then it was filtered. Finally, the 
mixture was kept on slow evaporation. This yielded 
dark brown coloured X-ray quality single crystals of 
the complex within a week. These were separated by 
filtration, washed and finally dried in vaccuo. 
Yield: 0.002 g (68%), Anal. for C11H16N4O3SCu (1): 
Calcd. (%), C, 46.46; H, 05.67, N, 19.70; found (%), C, 
46.41; H, 05.59; N, 19.75; Selected IR bands (KBr 
pellet, cm-1): 1586.20 (C=N), 776.78 (C-S); UV-visible 
absorption (λ, nm): 323, 405. 
 
Synthesis of [ZnL(OAc)]2(2) 
Ethanolic solutions of each of the L (20.80 mg,  
0.1 mmol) and zinc(II) acetate dihydrate (24.14 mg,  
0.1 mmol) were mixed and stirred for an hour. On 
stirring there was no appreciable colour change of the 
final solution which was filtered and kept on air for slow 
evaporation. After a week or so, intense yellow coloured 
single crystals were appeared. These were separated by 
filtration, washed and finally dried in vaccuo. 
Yield: 0.004 g (68%), Anal. for C22H28N8O4S2Zn2 
(2): Calcd. (%), C, 49.60; H, 5.29; N, 21.03; found (%), 
C, 49.56; H, 5.26; N, 21.11; Selected IR bands (KBr 
pellet, cm-1): 1582.00 (C=N), 752.72 (C-S); UV-visible 
absorption (λ, nm): 324; 1H NMR (CDCl3, 400 MHz): 
δH (ppm) = 2.53 (s, 3H), 7.64-8.79 (m, 4H), 1.98 (s, 




Cell viability assay 
The cell viability of samples (L, 1 and 2) were 
analysed by MTT [3-(4, 5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide] assay. Immortalized 
Human lung epithelial cell lines (L132) and Human 
lung cancer cell lines (A549) were used. 
Approximately 12,000 cells were seeded into 48 well 
culture plates and were incubated in CO2 incubator for 
24 h. Both cells were then treated with different 
concentrations [10 ng/mL, 25 ng/mL, 50 ng/mL,  
100 ng/mL, 250 ng/mL, 500 ng/mL, 1000 ng/mL] of 
all the five samples. After 24 h of incubation, the 
treatment medium was removed and the cells were 
treated with 0.5 mg/mL MTT salt. After 4 h of 
incubation, the purple coloured formazan crystals were 
solubilized in dimethyl sulfoxide and absorbance was 
read at 570 nm in Bio-Rad Elisa plate reader. The cell 
viability was calculated by the following formula 
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Reactive oxygen species (ROS) generation 
To determine the ROS generation, cells were 
treated with different concentrations of the sample. 
After 24 h of incubation, the cells were washed with 
phosphate-buffered saline and incubated with 5 µM 
2,7-dichlorofluorescin diacetate (DCFH-DA) in PBS 
for 30 min. After incubation, images of the cells were 
captured at 495 nm excitation and 523 nm emission 
(blue filter) using Leica DMi8 fluorescent 
microscope, Leica micro systems, Germany. 
 
Results and Discussion 
 
Synthesis and formulation 
Equimolecular mixture of 2-acetylpyridine and 
4-methyl-3-thiosemicarbazide were refluxed for 10 h to 
get the ligand L, which was characterized 
spectroscopically as well as X-ray crystallographically. 
In IR spectra, bands at 1606 and 779 cm-1 refers to 
respective imine and thione functions of the ligand12. In 
complexes, because of donation of electron density 
from the N- and S- donor centre the C=N (in imine) 
and C-S stretchings are expectedly decreased. In 1H 
NMR analysis (Supplementary Data, Fig. S1), a singlet 
peak is observed at 2.35 ppm is due to three methyl 
protons attached to the imine group. The terminal 
methyl protons attached with the secondary amine 
group are to some extent deshielded and the doublet 
signal at 3.22 ppm may be assigned for those. The 
terminal secondary amine proton which is very  
much deshielded expectedly appears at very much 
downfield (7.63 ppm) as multiplet. The four aromatic 
protons attached with the pyridine moiety appear at 
7.64-8.68 ppm as multiplet. For measuring the 
absorption spectra, ethanol is used as the solvent as L 
and its metal complexes (1 and 2) are soluble in ethanol. 
In absorption spectra, a band at 320 nm appears, which 
may be because of n-*/-* transition. In absorption 
studies, the complex (1) showed band in visible region.  
 
X-ray structures of L, 1 and 2 
Single crystal X-ray diffraction of the ligand L and 
the metal complexes (1 and 2) were done. The 
crystallographic parameters are listed in Table 1. 
Table 1 — Crystallographic parameters of L, 1 and 2 
Parameters L 1 2 
Formula C9H12N4S C11H16N4SO3Cu C22H30N8O4S2Zn2 
Mol. wt. 208.28 347.88 665.40 
Crystal system monoclinic Monoclinic monoclinic 
Space group P 21/c P 21/c P 21/n 
Temperature (K) 293 296 296 
Wavelength 1.54184 0.71073 0.71073 
a (Å) 8.8119(3) 7.03040(10) 10.5447(2) 
b (Å) 7.7228(2) 11.1579(2) 8.2796(2) 
c (Å) 15.5830(5) 19.4098(4) 16.1813(4) 
α (o) 90 90 90 
β (o) 106.125(3) 99.4140(10) 99.949(1) 
γ (o) 90 90 90 
V (Å3) 1018.74(6) 1502.09(5) 1391.48(6) 
Z 4 4 2 
Dc (g cm
−3) 1.358 2.393 1.588 
Μ (mm−1) 2.544 5.414 1.918 
F(000) 440.0 1050.0 684.0 
R(int) 0.044 0.0206 0.021 
Total reflections 8159 26816 23481 
I > 2σ(I) 2050 3404 2966 
Completeness to theta 0.976 0.996 0.997 
Absorption correction multi-scan multi-scan multi-scan 
 max and  min 79.23° and 5.24° 28.315° and 2.127° 28.30° and 2.15° 
Data/restraints/parameters 2149/0/130 3724/ 0/ 193 3445/0/176 
Goodness-of-fit (GOF) on F2 1.067 1.147 1.094 
Final R indices [l > 2s(l)] R1 = 0.0461 and wR2 = 0.1254 R1 = 0.0293 and wR2 = 0.0833 R1=0.0296 and wR2=0.0765 
R indices (all data) R1 = 0.0478 and wR2 = 0.1266 R1 = 0.0342 and wR2 = 0.0933 R1 = 0.0380 and wR2 = 0.0802 
Largest difference in peak and 
hole (eÅ-3) 
0.405, -0.303 0.616, -0.404 0.704, -0.514 





Thermal ellipsoid plot of L is given in Fig. 1a. 
Bond angles and bond distances of different bonds as 
calculated from the single crystal data are shown in 
Table 2. For L, the C-S bond distance is found to be 
1.6874(15) Å which is suggestive of the thione form9. 
 
CuL(OAc) (1) 
ORTEP representation of 1 is given in Fig. 1b. From 
Table 2, the bond distance and bond angles indicate a 
distorted square planar structure for the tetracoordinated 
Cu(II) centre in complex 1. The pyridine nitrogen 
(N(008)) and the thiolsulfur (S(002)), and the imine 
nitrogen (N(005)) and acetate oxygen (O(1)) are in trans 
position of the distorted square planar geometry. The 
difference between the maximum and minimum bond 
distances in the distorted square plane is 0.2779 Å. The 
C-S bond distance in the ligand backbone of 1 is 1.7503 
Å. This larger bond distance (2.23 Å) is suggestive of 
the thiolate form of the C-S bond of the L as well as +II 
oxidation level of the metal in the complex (as one 
acetate is coordinated with the metal)13. 
 
[ZnL(OAc)]2 (2) 
The molecular structure of 2 is presented in Fig. 1c. 
Each of the Zn(II) centre in the diacetato bridged 
dinuclear Zn(II) complex is five coordinated. 
According to  value calculation14 ( = 0.372) the 
geometry around each Zn(II) centre is assumed to have 
distorted square pyramidal. From bond angle bond 
distance data, the pyridine nitrogen (N(4)), imine 
nitrogen (N(3)), thiolsulphur (S(1)) and one oxygen 
atom (O1) forms the base of the square pyramid 
whereas another oxygen atom of the acetate bridge 
(O(2i)) forms the apex. The difference between the 
maximum and minimum bond distances in the plane is 
0.3862 Å. The larger bond distance (1.73 Å) here is 
suggestive of the thiolate form of the C-S bond of L13. 
 
Solution structures of 1 and 2 
Solution structures of 1 and 2 were determined using 
EPR and NMR measurements. EPR spectrum of 1 
(paramagnetic) in DMF and NMR spectrum of 2 
(diamagnetic) in CDCl3 were determined.  
 
EPR study of 1 
The anisotropic (axial) X-band EPR spectrum of 1 
in DMF solution at room temperature is given in 
Supplementary Data, Fig. S2. The spectrum is found to 
have superhyperfine splitting which results from the 
coupling of the nucleus of coordinating N with the 
Cu(II)15. This predicts that the solid-state structure was 
retained in solution. The g value was calculated as 
2.02983 (Supplementary Data, Calculation I). 
 
NMR analysis of 2 
In 1H NMR analysis of 2 (Supplementary Data, 
Fig. S3), the methyl protons attached to the carbon of 
the imine bond appear as singlet at 2.53 ppm, against 
the value of 2.35 ppm (Supplementary Data, Fig. S1) 
for free ligand. This is expected as the said protons 
are deshielded due to coordination of imine-N to the 
metal centre. The four aromatic protons attached to 
the pyridine moiety appear at 7.64–8.79 ppm as 
 
 
Fig. 1 — ORTEP plot of (a) ligand L and (b) complex 1 with 30% ellipsoid probability, and (c) complex 2 with 40% ellipsoid probability 




multiplet. This on comparison to the value in the case 
of free ligand indicates the coordination of the 
pyridine nitrogen to the metal centre leading to 
deshielding effect resulting in appearance of the 
signals downfield. Signal at 1.98 ppm (singlet) 
appears because of the six methyl protons of the 
bridging acetate. Another singlet at 3.10 ppm is due to 
the terminal methyl protons attached to the secondary 
amine group in the ligand framework. 
 
Anticancer activity 
The anticancer activities of all three compounds 
were tested and compounds L and 2 were found to be 
equally toxic to both normal and cancer cell lines, 
hence these compounds were not further used for 
anticancer study. Whereas IC50 value of 1 in cancer 
cell line and normal cell line were 250 ng/mL  
(0.72 M, in Supplementary Data, Calculation-II) and 
500 ng/mL (1.44 M, in Supplementary Data, 
Calculation-II and Fig. S4), respectively. The cell 
viability of normal cells was 93% up to 50 ng/mL of 1 
while cell viability of cancer cells was 59%. In order 
to study molecular mechanism behind cell death, ROS 
levels were analysed using the molecular probe  
2,7-dichlorofluorescein diacetate (DCFH-DA) (Fig. 2). 
The green fluorescence indicates the presence of ROS. 
DCFH-DA is the probe used for estimating the 
intracellular oxidative stress. The probe is cell 
permeable and on cellular uptake the probe is 
deacetylated by the intracellular esterase to a 
nonfluorescent DCFH carboxylate anion which in 
presence of ROS is oxidized to 2,7-dichlorofluorescein 
(DCF). DCF exhibits fluorescence which can be 
 
Table 2 — Bond angle and distance parameters of compounds 
Bond angles () 
L 
N(1)-C(5)-C(6) 115.59(14) N(3)-C(8)-S(1) 119.30(12) 
C(6)-N(2)-N(3) 118.13(13) N(3)-C(8)-N(4) 116.79(14) 
N(2)-N(3)-C(8) 118.53(13) N(4)-C(8)-S(1) 123.91(12) 
1 
N(005)-Cu(01)-O(1) 175.36(6) N(005)-Cu(01)-S(002) 85.04(4) 
N(005)-Cu(01)-N(008) 80.92(6) O(1)-Cu(01)-S(002) 96.82(5) 
O(1)-Cu(01)-N(008) 96.96(6) N(008)-Cu(01)-S(002) 165.63(4) 
2 
O(1)-Zn(01)-S(1)  111.32(5) O(2i)-Zn(01)-N(3) 130.44(6) 
O(1)-Zn(01)-O(2i)  117.11(6) O(2i)-Zn(01)-N(4) 88.34(6) 
O(1)-Zn(01)-N(3)  109.32(6) N(3)-Zn(01)-S(1) 80.70(5) 
O(1)-Zn(01)-N(4)  89.23(6) N(3)-Zn(01)-N(4) 75.53(7) 
O(2i)-Zn(01)-S(1)  97.24(5) N(4)-Zn(01)-S(1) 152.76(5) 
O(1i)-Zn(01i)-S(1i)  111.32(5) O(2)- Zn(01i)-N(3i) 130.44(6) 
O(1i)- Zn(01i)-O(2)  117.11(6) O(2)- Zn(01i)-N(4 i) 88.34(6) 
O(1i)- Zn(01i)-N(3 i)  109.32(6) N(3 i)- Zn(01i)-S(1i) 80.70(5) 
O(1 i)- Zn(01i)-N(4 i)  89.23(6) N(3 i)- Zn(01i)-N(4i) 75.53(7) 
O(2)- Zn(01i)-S(1i)  97.24(5) N(4 i)- Zn(01i)-S(1i) 152.76(5) 
Bond distances (Å) 
L 
C(6)-N(2) 1.282(2) N(4)-C(8) 1.320(2) 
N(2)-N(3) 1.3762(18) C(8)-S(1) 1.6874(15) 
N(3)-C(8) 1.3640(19)   
1 
Cu(01)- N(005) 1.9529(14) Cu(01)- N(008) 2.0087(15) 
Cu(01)- O(1) 1.9536(12) Cu(01)- S(002) 2.2308(5) 
S(002)-C(00C) 1.7503(19)   
2 
Zn(01)-S(1)  2.3679(6) Zn(01)-O(2) 2.0135(14) 
Zn(01)-O(1)  1.9817(14) Zn(01)-N(3) 2.1076(17) 
Zn(01)-N(4)  2.1408(17) Zn(01i)-S(1 i) 2.3679(6) 
Zn(01 i)-O(2 i)  2.0135(14) Zn(01i)-O(1 i) 1.9817(14) 
Zn(01 i)-N(3 i)  2.1076(17) Zn(01i)-N(4 i) 2.1408(17) 
S(1)-C(2)  1.730(2)   
 




measured using a fluorescence microscope with 
excitation and emission at 485 nm and 535 nm, 
respectively. The ROS generation of control (C) cells 
was significantly low whereas, upon treatment with 1, 
a significant ROS generation was observed in cancer 
cells. The ROS generation in normal cell was 
comparatively lower than that of the cancer cell. The 
increase in the ROS results in oxidant challenge to the 
cell which results in activation of cell death pathway 
finally resulting in the death of the cell. The result 
indicate that the treatment of 1 results in activation of 
high ROS challenge in cancer cells indicating that at 
the concentration used it specifically kills the cancer 
cell sparing the normal cells. The results thus 
indicated that the cell death mediated by 1 was 
observed to be through ROS generation. Mn(II) 
complex of the same ligand and its cytotoxicity 
against cancerous cells were previously reported13. 
The anticancer activity of this Cu(II) complex of L is 
a new addition to the existing literature in this field. 
Copper is one of the essential elements in various 
physiological processes and binds with DNA resulting 
in its damage and cell apoptosis through ROS 
formation17. The may be the reason for the better 
activity of 1 than 2 towards cancer cell lines. 
 
Conclusions 
Thiosemicarbazone ligand and its Cu(II) and Zn(II) 
complexes were synthesized and crystallographically 
characterized. Among these three, the Cu complex has 
shown promising anticancer activity against human 
lung cancer cell line. It is interesting to note that the 
IC50 value of this complex is almost 10
3 times lower 
than standard cisplatin. IC50 values of cisplatin against 
A549 cell line is 6 M16, whereas the value for Cu 
complex is less than 1 M (0.72 M). The molecular 
mechanism behind cell death in cancer cell lines using 
the concerned compound is found to be through the 
formation of reactive oxygen species. 
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